SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr | ₹58 Cr |
What is the latest Total Liabilities ratio of SAMRAT PHARMACHEM ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹117 Cr |
Mar2022 | ₹85 Cr |
Mar2021 | ₹57 Cr |
Mar2020 | ₹58 Cr |
How is Total Liabilities of SAMRAT PHARMACHEM Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | 4.41 | |
Mar2023 | ₹117 Cr | 37.79 | |
Mar2022 | ₹85 Cr | 47.42 | |
Mar2021 | ₹57 Cr | -1.63 | |
Mar2020 | ₹58 Cr | - |
Compare Total Liabilities of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹109.3 Cr | -4.7% | 2.2% | 6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -4.7% |
2.2% |
6% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses